The 1st randomized trial of a booster (3rd) shot in 10,000 people, placebo-controlled, shows 95.6% efficacy, with 5 cases (Pfizer vaccine) vs 109 in placebo group, Delta variant, broad benefit across age groups ft.com/content/d4e58d…
Until now there were only vaccine effectiveness reports without randomization, without a placebo control group, and multiple potential confounding factors. That’s what makes this trial report significant proof of benefit of booster shots, at least for this vaccine regimen.
@EricTopol Who did write this shit ? First thing, it indicates that median time between second and third doses was about 11 months. Where did those people get a second dose October or November last year where fist dose started December ?
@EricTopol How long will it last though? Realistically boosting more than once a year is very unrealistic except for healthcare workers and maybe very vulnerable people. Maybe if covid becomes seasonal we could manage with one dose?
@EricTopol I had better not hear anyone say “the vaccine works, it keeps you out of the hospital or from getting a severe case”. It was sold to us to “prevent” infection. When it didn’t they changed the narrative.
@EricTopol That’s 95.6% effective as compared to two doses + placebo! 🤯